Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.

Ogbogu PU, Bochner BS, Butterfield JH, Gleich GJ, Huss-Marp J, Kahn JE, Leiferman KM, Nutman TB, Pfab F, Ring J, Rothenberg ME, Roufosse F, Sajous MH, Sheikh J, Simon D, Simon HU, Stein ML, Wardlaw A, Weller PF, Klion AD.

J Allergy Clin Immunol. 2009 Dec;124(6):1319-25.e3. doi: 10.1016/j.jaci.2009.09.022.

2.

[Disorders with eosinophilia, treatment of hypereosinophilic syndrome].

Borbényi Z.

Orv Hetil. 2005 May 1;146(18 Suppl 1):911-6. Review. Hungarian.

PMID:
15921304
3.

Current strategies in the management of hypereosinophilic syndrome, including mepolizumab.

Schwartz LB, Sheikh J, Singh A.

Curr Med Res Opin. 2010 Aug;26(8):1933-46. doi: 10.1185/03007995.2010.493132. Review.

PMID:
20565230
4.

Novel approaches to therapy of hypereosinophilic syndromes.

Simon HU, Cools J.

Immunol Allergy Clin North Am. 2007 Aug;27(3):519-27. Review.

PMID:
17868862
5.

[Oncogene Fip1-likeL/PDGFRalpha as a target for imatinib in patients with hypereosinophilic syndrome and chronic eosinophilic leukemia. A novel look at pathogenesis and therapy].

Helbig G, Stella-Hołowiecka B, Hołowiecki J.

Pol Arch Med Wewn. 2005 May;113(5):490-7. Review. Polish. No abstract available.

PMID:
16479834
6.

Murine model of hypereosinophilic syndromes/chronic eosinophilic leukemia.

Yamada Y, Cancelas JA, Rothenberg ME.

Int Arch Allergy Immunol. 2009;149 Suppl 1:102-7. doi: 10.1159/000211381. Epub 2009 Jun 3. Review.

PMID:
19494514
7.

The hypereosinophilic syndromes: current concepts and treatments.

Gleich GJ, Leiferman KM.

Br J Haematol. 2009 May;145(3):271-85. doi: 10.1111/j.1365-2141.2009.07599.x. Review.

PMID:
19243381
8.

Management of Hypereosinophilic Syndromes.

Roufosse F.

Immunol Allergy Clin North Am. 2015 Aug;35(3):561-75. doi: 10.1016/j.iac.2015.05.006. Review.

PMID:
26209900
9.

Imatinib therapy for hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders.

Pardanani A, Tefferi A.

Leuk Res. 2004 May;28 Suppl 1:S47-52. Review.

PMID:
15036941
10.

The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management.

Gotlib J, Cools J, Malone JM 3rd, Schrier SL, Gilliland DG, Coutré SE.

Blood. 2004 Apr 15;103(8):2879-91. Epub 2003 Nov 20. Review.

11.

FIP1L1-PDGFR alpha, a therapeutic target for the treatment of chronic eosinophilic leukemia.

Cools J.

Verh K Acad Geneeskd Belg. 2005;67(3):169-76. Review.

PMID:
16089297
12.

Eosinophilia in mast cell disease.

Kovalszki A, Weller PF.

Immunol Allergy Clin North Am. 2014 May;34(2):357-64. doi: 10.1016/j.iac.2014.01.013. Epub 2014 Mar 13. Review.

13.

A critical appraisal of conventional and investigational drug therapy in patients with hypereosinophilic syndrome and clonal eosinophilia.

Kalac M, Quintás-Cardama A, Vrhovac R, Kantarjian H, Verstovsek S.

Cancer. 2007 Sep 1;110(5):955-64. Review.

14.

Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants.

Roufosse F, Goldman M, Cogan E.

Semin Respir Crit Care Med. 2006 Apr;27(2):158-70. Review.

PMID:
16612767
15.

Diagnostic and therapeutic management in patients with hypereosinophilic syndromes.

Helbig G, Kyrcz-Krzemień S.

Pol Arch Med Wewn. 2011 Jan-Feb;121(1-2):44-52. Review.

16.

Treatment of hypereosinophilic syndromes--the first 100 years.

Butterfield JH, Weiler CR.

Semin Hematol. 2012 Apr;49(2):182-91. doi: 10.1053/j.seminhematol.2012.01.001. Review. Erratum in: Semin Hematol. 2012 Oct;49(4):361.

PMID:
22449628
17.
18.

Platelet-derived growth factor receptor inhibition to treat idiopathic hypereosinophilic syndrome.

Stone RM, Gilliland DG, Klion AD.

Semin Oncol. 2004 Apr;31(2 Suppl 6):12-7. Review.

PMID:
15175999
19.

[Hypereosinophilic syndrome--recent developments in diagnosis and treatment].

Hellmich B, Holl-Ulrich K, Gross WL.

Dtsch Med Wochenschr. 2007 Sep;132(37):1892-6. Review. German.

PMID:
17823882
20.

Novel therapies for hypereosinophilic syndromes.

Antoniu SA.

Neth J Med. 2010 Aug;68(1):304-10. Review.

Supplemental Content

Support Center